Mar
14
2019
On demand

Critical components for developing and managing expansive, high-performing collection networks

The success of a cell or gene therapy depends on the collection of high-quality starting material, which in turn relies heavily on apheresis and collection professionals receiving applicable, highly-specialized training and ongoing support and protocol management for each unique product. With the rapid growth in cell therapy clinical trials, proven experience and shared knowledge of the apheresis infrastructure and cell therapy industry is essential to the development and management of high-performing collection networks.

Watch this On Demand webinar with Amy Hines and Richard Smith of Be The Match BioTherapies, and expert guest panellists:

  • Joseph Vitale, PhD, Hitachi Chemical Advanced Therapeutics Solutions, LLC
  • Sanjin Zvonić, PhD, WindMIL Therapeutics
  • Richard J. Smith, Be The Match BioTherapies, United Kingdom

At the end of this On Demand webinar viewers will have a strong understanding of:

  • The importance of high-quality starting material for the success of a new cell and gene therapy, challenges associated with cell collection and the resource burden currently impacting collection center infrastructure
  • The necessity of standardized cell collection processes to obtain consistent, compliant and high-quality cell starting materials
  • Proven strategies for the effective and efficient qualification and onboarding of collection sites
  • Efficiencies that can be gained by leveraging partners with established relationships in the apheresis and collection environment

The On Demand webinar attendance is free of charge.


Amy Hines
Senior Manager, Network Development at Be The Match BioTherapies
Richard Smith
Consultant, Cell Therapy at Be The Match BioTherapies
Joseph Vitale
Director, Account Management at Hitachi Chemical Advanced Therapeutics Solutions
Sanjin Zvonic


SPEAKERS

Amy Hines
Senior Manager, Network Development at Be The Match BioTherapies
Richard Smith
Consultant, Cell Therapy at Be The Match BioTherapies
Joseph Vitale
Director, Account Management at Hitachi Chemical Advanced Therapeutics Solutions
Sanjin Zvonic

You might also like

Thinking translational: Things to consider in CAR T cell research workflows

S Rösch, PhD
Saskia Rösch, PhD
Saskia Rösch, PhD
Global Product Manager at Miltenyi Biotec
22 Jun 2022
35
Days
0
Hrs
18
Min
Register

Optimizing mRNA purification conditions by using a Design of Experiments...

J England
Jenny England
Jenny England
Application Scientist and Innovation Leader at Thermo Fisher Scientific
14 Jun 2022
27
Days
0
Hrs
18
Min
Register

Monitoring of circulating CAR T cells

A Graband,
D Hünecke,
D Bremm
Annika Graband
Annika Graband
Product Manager, Cell Analysis Reagents at Miltenyi Biotec
Dr. Sabine Hünecke
Dr. Sabine Hünecke
Head of Laboratory, Stem Cell Transplantation and Immunotherapy at University Hospital Frankfurt
Dr. Melanie Bremm
Dr. Melanie Bremm
Deputy Head of Laboratory, Stem Cell Transplantation and Immunotherapy at University Hospital Frankfurt
31 May 2022
13
Days
0
Hrs
18
Min
Register

Improving T cell therapy manufacturing processes with automation and...

E Zynda, PhD
Evan Zynda, PhD
Evan Zynda, PhD
Staff Scientist, Cell Biology at Thermo Fisher Scientific
26 May 2022
8
Days
0
Hrs
18
Min
Register

Streamlined workflow solutions for cell and gene therapy analytics

A Graband
Annika Graband
Annika Graband
Product Manager, Cell Analysis Reagents at Miltenyi Biotec
24 May 2022
6
Days
0
Hrs
18
Min
Register